Delivery Order SPE2DB22D3011-SPE2DB24FP9MV
Award Date 2/28/24
Potential Completion Date 2/29/24
Potential Value $2.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZONISADE 100 MG/5 ML ORAL SUSP 150ML, a pharmaceutical product, with a ceiling value of $1,122.49 and a period of performance through March 28, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation indicated. AmerisourceBergen holds...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ZONISADE 100 MG/5 ML ORAL SUSP 150ML. The contract has a ceiling value of $4,770.65 and a period of performance through November 30, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle...
- The federal contract award summarized here is for the delivery of the pharmaceutical product "ZONISADE 100 MG/5 ML ORAL SUSP 150ML" to the Defense Logistics Agency (DLA). The contract, valued at $4,354.19, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 15, 2023. The contract is not designated with any...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,290.07 for Zonisade 100 mg/5 mL oral suspension (150 mL) on November 20, 2025, with completion scheduled for November 21, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor and critical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Zonisade 100 mg/5 ml oral suspension, a pharmaceutical product, with a ceiling value of $1,546.43. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 15, 2025. The contract was awarded on April 14, 2025, and was not set aside...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,930.33, is for the delivery of ZONISADE 100 MG/5 ML ORAL SUSP 150ML, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This delivery order from the Defense Logistics Agency awards Amerisourcebergen Drug Corp $1,487.31 to supply 150ml of the oral suspension Zonisade 100 mg/5 ml. As the parent company, Amerisourcebergen Corporation will perform under the contract through its Corporate Office location in Conshohocken, Pennsylvania. The firm fixed price contract has an anticipated completion date of October 18, 2023 and did not utilize any set aside designations in the award. The Defense Logistics Agency supports...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,461.70 to AmerisourceBergen Drug Corp for the supply of Zonisade 100 mg/5 ml oral suspension in a 150 ml quantity. This firm fixed-price delivery order, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX. The contract was competitively awarded with no...
- This federal contract award is for the delivery of the pharmaceutical product "ZONISADE 100 MG/5 ML ORAL SUSP 150ML" to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $2,209.66, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that provides a wide range of medications and medical supplies to various federal agencies, particularly the Department of Defense and the Department of...
- This federal contract award, valued at $11,573.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to deliver the medication Zonisade 100 mg/5 ml oral suspension in 150 ml bottles. This award is a delivery order under an Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical, which provides a wide range of medical commodities to support military treatment programs and facilities...